Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial (Q42650874)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial |
scientific article |
Statements
1 reference
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial (English)
1 reference
C Warren Olanow
1 reference
William J Marks
1 reference
Jill L Ostrem
1 reference
Leonard Verhagen
1 reference
Philip A Starr
1 reference
Paul S Larson
1 reference
Roy Ae Bakay
1 reference
Robin Taylor
1 reference
Deborah A Cahn-Weiner
1 reference
A Jon Stoessl
1 reference
Raymond T Bartus
1 reference
2 April 2008
1 reference
1 reference
Identifiers
1 reference